SPOTLIGHT -
Bladder Cancer Market to "More than Triple to Over $1.1 billion by 2025"
Collaboration to Simplify Document Exchange in Clinical Trials
UK-US Collaboration to Boost Research Against "Undruggable" RAS
Breast Cancer Market in Southeast Asia “to hit $2.7 billion by 2022”
UK Pharma Ahead of France and Germany in Diversity
Bial Launches International Campaign for World Parkinson's Day
Rheumatoid Arthritis Market in Southeast Asia "to Reach $1.44 Billion by 2022"
Expert Claims Healthcare Cybersecurity is “Worse Than Reported”
Payers Not Impressed with HEOR Measures
Cystic Fibrosis Market Expected at $7.6 Billion by 2025
A Faster, More Flexible, and Frugal FDA?
Jill Wechsler outlines how the new FDA commissioner tasked with curbing regulation, speeding approvals-and collecting more fees to do it.
Pharmaceutical Executive, April 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2017 issue in an interactive PDF format.
Survey Examines Pharm Technology Uses
UK BioIndustry Association Looks to Switzerland for Post-Brexit Options
March 28, 2017
Drop in US Drug Approvals But No Similar Trend in EU
University of Dundee Wins UK Grant to Boost Discovery of New Antibacterial Drugs
March 27, 2017
TB Alliance Sublicenses Anti-tuberculosis Drug from the Medicines Patent Pool
March 24, 2017
CPhI Japan: New Opportunities for International Pharmaceutical Manufacturers
March 20, 2017
Eurofins Invests in Scotland Facility
NICE "No" to Opdivo
March 15, 2017
Allergan and Editas Medicine Strike R&D Alliance for Eye Diseases
March 14, 2017
CDER Director Details Priorities for 2017
March 10, 2017
Big Money and Big Data
No longer just hype, investing in big data is the path to the future for pharma, even if big returns aren't a direct result.
CPhI China to Host China Pharma Week
March 07, 2017
European Industry Associations Call for Strict Policy Measures on Off-Label Use
March 03, 2017
CPhI Expands in Middle East & Africa
March 01, 2017
Median Cost Per Patient for Orphan Drugs is 5.5 Times Higher Than Non-Orphan Drugs
Changing Faces: The Interim Manager
A look at how pharma and biotech interim management has evolved in the last 20 years.
Pharmaceutical Executive, March 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2017 issue in an interactive PDF format.
Uphill Work to Realize Dreams of Rare Disease Treatment
February 28, 2017
